or Try an Advanced Search...

    Technical Analysis for SEEL - Seelos Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 2.32 0.11% 0.00
    SEEL closed up 19.72 percent on Wednesday, May 15, 2024, on 3.96 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical SEEL trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.11%
    Pocket Pivot Bullish Swing Setup 0.11%
    Volume Surge Other 0.11%
    Wide Bands Range Expansion 0.11%
    Oversold Stochastic Weakness 0.11%
    New 52 Week Closing Low Bearish 19.85%
    New 52 Week Low Weakness 19.85%
    Earnings Movers Other 19.85%
    Wide Bands Range Expansion 19.85%
    Below Lower BB Weakness 19.85%
    Older End-of-Day Signals for SEEL ...

       Recent Intraday Alerts

    Alert Time
    Rose Above 10 DMA 42 minutes ago
    2x Volume Pace 42 minutes ago
    1.5x Volume Pace 42 minutes ago
    3x Volume Pace 42 minutes ago
    Down 5% 42 minutes ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    SEEL Chart by TradingView
    Basic chart:

    Profile

    Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders. The Company’s robust portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders, including orphan diseases. Seelos is based in New York, New York.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Disorders Movement Disorders Orphan Disease

    Is SEEL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 14 Seelos Therapeutics Announces 1-for-8 Reverse Stock Split
    Mar 19 Dow Jumps 200 Points; Core & Main Shares Gain After Q4 Results
    Mar 19 Seelos drops as lead drug fails in ALS trial
    Mar 19 UPDATE 2-Seelos Therapeutics' ALS treatment fails mid-stage study
    Mar 19 Seelos Therapeutics Provides Update on Top-Line Results from its Amyotrophic Lateral Sclerosis (ALS) Study with SLS-005 (IV Trehalose)
    Mar 7 Mind Medicine sends psychedelic stocks higher after FDA status for LSD formulation
    Jan 27 Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
    Jan 26 Seelos Therapeutics announces equity and warrants offering for gross proceeds of $4M
    Jan 26 Seelos Therapeutics, Inc. Announces $4.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
    Jan 22 Seelos Therapeutics Announces Receipt of Minutes from its End of Phase II Meeting with the United States Food and Drug Administration (FDA) Highlighting Modifications to the Primary and Secondary Endpoints of its Phase II Study of SLS-002
    See more SEEL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 398.4
    52 Week Low 1.92
    Average Volume 63,002
    200-Day Moving Average 64.11
    50-Day Moving Average 4.27
    20-Day Moving Average 2.40
    10-Day Moving Average 2.34
    Average True Range 0.40
    RSI (14) 37.89
    ADX 37.86
    +DI 13.54
    -DI 27.97
    Chandelier Exit (Long, 3 ATRs) 2.33
    Chandelier Exit (Short, 3 ATRs) 3.11
    Upper Bollinger Bands 2.81
    Lower Bollinger Band 1.98
    Percent B (%b) 0.41
    BandWidth 34.54
    MACD Line -0.54
    MACD Signal Line -0.65
    MACD Histogram 0.1096
    Fundamentals Value
    Market Cap 31.76 Million
    Num Shares 13.7 Million
    EPS -12.90
    Price-to-Earnings (P/E) Ratio -0.18
    Price-to-Sales 7.03
    Price-to-Book 15.10
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.96
    Resistance 3 (R3) 2.93 2.68 2.86
    Resistance 2 (R2) 2.68 2.52 2.70 2.82
    Resistance 1 (R1) 2.50 2.42 2.59 2.54 2.78
    Pivot Point 2.25 2.25 2.30 2.27 2.25
    Support 1 (S1) 2.07 2.09 2.16 2.11 1.86
    Support 2 (S2) 1.83 1.99 1.84 1.82
    Support 3 (S3) 1.65 1.83 1.79
    Support 4 (S4) 1.68